The US Food and Drug Administration (FDA) has approved AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for ...

The spray could be an alternative for people who are averse to getting injections, or otherwise find it difficult or ...

The U.S. Food and Drug Administration (FDA) has approved FluMist for self-administration. On Friday, the FDA announced that ...

The US Food and Drug Administration has approved first self- or caregiver-administered flu vaccine FluMist.FluMist is ...

US FDA approves AstraZeneca’s needle-free nasal spray, FluMist for self-administration: Cambridge, UK Monday, September 23, 2024, 09:00 Hrs [IST] AstraZeneca, a global, science- ...

FluMist is the first vaccine to prevent influenza, more commonly known as the flu, that does not need to be administered by a ...

A nasal spray flu vaccine for people up to 49 will be available for home use starting in the fall of 2025 after the Food and ...

In a first, the US Food and Drug Administration on Friday approved a nasal spray flu vaccine for self-administration.

There are needle-free options for getting the flu vaccine, such as FluMist, which has been available for many years as a ...

The vaccine FluMist, manufactured by MedImmune, which was acquired by AstraZeneca in 2007, was first approved by the FDA in 2003 for individuals between five and 49 years of age. Its approval has ...

The FDA approved the first flu vaccine that does not have to be administered by a health care provider, but it won’t be available in time for this respiratory virus season.

WASHINGTON (AP) — Starting this month, Americans will be able to order free COVID-19 test kits that will be mailed to their ...